Wells Fargo
TIL icon

Wells Fargo’s Instil Bio TIL Stock Holding History

Wells Fargo’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31
Closed -$335 – 7454
2024
Q1 		$335 Hold
31
– – ﹤0.01% 6374
2023
Q4 		$236 Buy
31
+3
+11% +$22 ﹤0.01% 6571
2023
Q3 		$240 Buy
28
+5
+22% +$50 ﹤0.01% 6540
2023
Q2 		$248 Sell
23
-593
-96% -$7.25K ﹤0.01% 6638
2023
Q1 		$8.14K Buy
+616
New +$9.1K ﹤0.01% 5924
2022
Q4 		– Sell
-7
Closed -$1K – 7725
2022
Q3 		$1K Sell
7
-20
-74% -$2.29K ﹤0.01% 6473
2022
Q2 		$2K Buy
+27
New +$3.82K ﹤0.01% 6379
2022
Q1 		– Sell
-939
Closed -$321K – 7805
2021
Q4 		$321K Buy
+939
New +$362K ﹤0.01% 5002

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wells Fargo's TIL Position: Q2 2024 in Review

Wells Fargo sold out of Instil Bio (TIL) in Q2 2024, closing a stake of 31 shares — an estimated $335 sold.

Wells Fargo first reported a position in TIL in Q4 2021 and held it in 8 quarters. The position peaked at $321K in Q4 2021. 30 funds tracked by Wall St. Rank hold TIL as of Q2 2024.

  • Wells Fargo reported no remaining Instil Bio position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 31 Instil Bio shares in Q2 2024, an estimated $335.
  • Wells Fargo first reported a position in Instil Bio in Q4 2021 and held it in 8 quarters.
  • Wells Fargo's Instil Bio position peaked at $321K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Instil Bio as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.